IDXX

#339
IDEXX Laboratories, Inc. - Common Stock
571.4 3 USD
+0.46%
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
563.70
573.00
Range Annuel
504.56
769.98
Changement quotidien
+0.46%
Changement Mensuel
+3.08%
Evolution sur 6 mois
-22.97%
Changement Annuel
+11.11%
Clôture Précédente
568.8 4
Open
567.4 1
Low
563.7 0
High
573.0 0
Volume
231
Afficher le graphique complet Full chart

Financials

Aperçu Relevé Statistiques
Trimestriel Annuel
  • Market Capitalization 45.08 B
  • Employee 11 K
  • Founded 1983
  • CEO Jay Mazelsky
  • Website www.idexx.com
  • Headquarter Delaware, United States
  • FIGI BBG000BLRT07
  • Industry Diagnostic et Recherche
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
51.72
ratio cours/chiffre d'affaires
12.76

IDEXX Laboratories, Inc. - Common Stock

IDEXX Laboratories, Inc. is an American multinational corporation engaged in the development, manufacture, and distribution of products and services for the companion animal veterinary, livestock and poultry, water testing, and dairy markets. Incorporated in 1983 by David Evans Shaw, the company is headquartered in Westbrook, Maine, and in Hoofddorp, Netherlands for its EMEA divisions. IDEXX offers products to customers in over 175 countries around the world and employs approximately 9,200 people in full-and part-time positions. There are three main segments of the company: Companion Animal Group, Water, and Livestock, Poultry and Dairy. In addition, the company also manufactures and sells pet-side SNAP tests for a variety of animal health diagnostic uses. In 2002, Jon Ayers succeeded company founder Shaw as chairman and CEO. During Ayers 20-year tenure, the company's annual revenue grew from $380 million to $3 billion, raising share prices by more than 100 times. In 2019, Jay Mazelsky succeeded Ayers in the role of CEO.

Nouvelles